Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | digitoxigenin | 14052 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | digitoxigenin | 14052 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | digitoxigenin | 14052 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | digitoxigenin | 14052 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | digitoxigenin | 14052 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | digitoxigenin | 14052 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | digitoxigenin | 14052 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | digitoxigenin | 14052 | drug-path |
| Base excision repair | R-HSA-73884 | map03410 | digitoxigenin | 14052 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | digitoxigenin | 14052 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | digitoxigenin | 14052 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | digitoxigenin | 14052 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | digitoxigenin | 14052 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | digitoxigenin | 14052 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | digitoxigenin | 14052 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | buflomedil | 73341 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | buflomedil | 73341 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | buflomedil | 73341 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | buflomedil | 73341 | drug-path |
| Asthma | R-HSA-444620 | map05310 | buflomedil | 73341 | drug-path |